Gainesville, Fla. (April 12, 2016) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its first quarter financial results after the market closes on Tuesday, April 26, 2016. A copy of the earnings release will be available at https://www.hawkassociates.com.
The company will hold a conference call with CEO David Petty and key members of the management team on Wednesday, April 27 at 10 a.m. EST. The call will cover Exactech’s first quarter results. Petty will open the conference call, and a question-and-answer session will follow.
To participate in the call, dial 1-888-556-4997 any time after 9:50 a.m. EST on April 27. International and local callers should dial 1-719-325-2464. A live webcast of the call will be available at https://www.hawkassociates.com/profile/exac.cfm or https://public.viavid.com/index.php?id=119078.
This call will be archived for approximately 90 days.
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech Inc. can be found at https://aigrenoble.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at https://aigrenoble.com andhttps://www.hawkassociates.com.
An investment profile on Exactech may be found at https://www.hawkassociates.com/profile/exac.cfm. To receive future releases in email alerts, sign up at https://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.
Executive Vice President of Finance & Chief Financial Officer
Julie Marshall or Frank Hawkins
Vice President, Corporate & Marketing Communication